RTM receives marketing authorisation for Fludeoxyglucose (18F)
We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018.
Fludeoxyglucose (18F) RTM 200 MBq/ml, solution for injection will become commercially available in The Netherlands in October, with roll-out to Belgium and Germany planned in 2019.
![RTM receives marketing authorisation for Fludeoxyglucose (18F)](https://radboudtranslationalmedicine.nl/cdn/b4cab29f-4a7a-4a09-a1d0-568d3e3446ea/-/resize/555x/-/format/auto/-/quality/smart/plc04276-hr.jpg)
Other news
![RTM added as distributor NeuraCeq®](https://radboudtranslationalmedicine.nl/cdn/c23b15a6-eef5-4843-a143-f51c61ba0b6a/-/smart_resize/250x170/-/format/auto/-/quality/smart/neuraceq.png)
RTM added as distributor NeuraCeq®
Exciting news! Life Molecular Imaging’s NeuraCeq® 300 MBq/ml solution for injection (florbetaben 18F...
![18F-FDOPA now available](https://radboudtranslationalmedicine.nl/cdn/dde0a2a7-a571-4ff2-924d-3fd7f3a0878f/-/smart_resize/250x170/-/format/auto/-/quality/smart/041radboud-ossip.jpg)
18F-FDOPA now available
Fluorodopa (18F) is now available for clinical studies and - with doctor's certificate - for routine...
![Production of novel diagnostic radionuclides in small medical cyclotrons](https://radboudtranslationalmedicine.nl/cdn/25b47553-0ca5-49e8-a955-014516c0947d/-/smart_resize/250x170/-/format/auto/-/quality/smart/026radboud-ossip.jpg)
Production of novel diagnostic radionuclides in small medical cyclotrons
Employees from RTM and Radboudumc have published a new article: 'Production of novel diagnostic radi...
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany
ABX has received marketing authorisation for the radiotracer Radelumin® in Germany! This marks the 8...
Interested in a collaboration?
Contact us to discuss the possibilities.